APA

Maguire M., Shortino D., Klein A., Harris W., Manohitharajah V., Tisdale M., Elston R., Yeo J., Randall S., Xu F., Parker H., May J. & Snowden W. (20020611). Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors. : Antimicrobial agents and chemotherapy.

Chicago

Maguire Michael, Shortino Denise, Klein Astrid, Harris Wendy, Manohitharajah Varsha, Tisdale Margaret, Elston Robert, Yeo Jane, Randall Sharon, Xu Fan, Parker Hayley, May Jackie and Snowden Wendy. 20020611. Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors. : Antimicrobial agents and chemotherapy.

Harvard

Maguire M., Shortino D., Klein A., Harris W., Manohitharajah V., Tisdale M., Elston R., Yeo J., Randall S., Xu F., Parker H., May J. and Snowden W. (20020611). Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors. : Antimicrobial agents and chemotherapy.

MLA

Maguire Michael, Shortino Denise, Klein Astrid, Harris Wendy, Manohitharajah Varsha, Tisdale Margaret, Elston Robert, Yeo Jane, Randall Sharon, Xu Fan, Parker Hayley, May Jackie and Snowden Wendy. Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors. : Antimicrobial agents and chemotherapy. 20020611.